. . . "Peror\u00E1ln\u00ED aplikace \nPoruchy souvisej\u00EDc\u00ED s deficitem progesteronu, zejm\u00E9na: \n- premenstrua\u010Dn\u00ED syndrom; \n- menstrua\u010Dn\u00ED nepravidelnost zp\u016Fsoben\u00E1 dysovulac\u00ED nebo anovulac\u00ED; \n- benign\u00ED mastopatie; \n- premenopauza; \n- hormon\u00E1ln\u00ED substitu\u010Dn\u00ED terapie menopauzy (jako dopln\u011Bk k terapii estrogeny). \nVagin\u00E1ln\u00ED aplikace: ve v\u0161ech ostatn\u00EDch indikac\u00EDch progesteronu vagin\u00E1ln\u00ED aplikace je alternativou aplikace peror\u00E1ln\u00ED v p\u0159\u00EDpad\u011B: \n- ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F progesteronu (somnolence po peror\u00E1ln\u00EDm pod\u00E1n\u00ED); \n- kontraindikace peror\u00E1ln\u00ED aplikace (hepatopatie). \n"@cs . "4.1. Terapeutick\u00E9 indikace "@cs . "004.001" .